See more : Ashiana Housing Limited (ASHIANA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Walgreens Boots Alliance, Inc. (WBA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Walgreens Boots Alliance, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401.SZ) Income Statement Analysis – Financial Results
- Shandong Huifa Foodstuff Co.,Ltd. (603536.SS) Income Statement Analysis – Financial Results
- Kindstar Globalgene Technology, Inc. (9960.HK) Income Statement Analysis – Financial Results
- Bakkavor Group plc (BAKK.L) Income Statement Analysis – Financial Results
- Strategic Investments A/S (STRINV.CO) Income Statement Analysis – Financial Results
Walgreens Boots Alliance, Inc. (WBA)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.66B | 139.08B | 132.70B | 132.51B | 121.98B | 120.07B | 131.54B | 118.21B | 117.35B | 103.44B | 76.39B | 72.22B | 71.63B | 72.18B | 67.42B | 63.34B | 59.03B | 53.76B | 47.41B | 42.20B | 37.51B | 32.51B | 28.68B | 24.62B | 21.21B | 17.84B | 15.31B | 13.36B | 11.78B | 10.40B | 9.24B | 8.29B | 7.48B | 6.73B | 6.05B | 5.38B | 4.88B | 4.28B | 3.66B | 3.16B |
| Cost of Revenue | 121.13B | 112.01B | 104.44B | 104.44B | 95.91B | 91.92B | 100.75B | 89.05B | 87.48B | 76.59B | 54.82B | 51.10B | 51.29B | 51.69B | 48.44B | 45.72B | 42.39B | 38.52B | 34.24B | 30.41B | 27.31B | 23.71B | 21.08B | 18.05B | 15.24B | 12.77B | 10.95B | 9.52B | 8.37B | 7.35B | 6.50B | 5.85B | 5.29B | 4.74B | 4.29B | 3.78B | 3.41B | 2.95B | 2.51B | 2.16B |
| Gross Profit | 26.52B | 27.07B | 28.27B | 28.07B | 26.08B | 28.16B | 30.79B | 29.16B | 29.87B | 26.86B | 21.57B | 21.12B | 20.34B | 20.49B | 18.98B | 17.61B | 16.64B | 15.24B | 13.17B | 11.79B | 10.20B | 8.80B | 7.61B | 6.57B | 5.97B | 5.07B | 4.36B | 3.85B | 3.41B | 3.04B | 2.74B | 2.44B | 2.19B | 1.99B | 1.76B | 1.60B | 1.47B | 1.33B | 1.15B | 1.00B |
| Gross Profit Ratio | 17.96% | 19.46% | 21.30% | 21.18% | 21.38% | 23.45% | 23.41% | 24.67% | 25.46% | 25.96% | 28.23% | 29.24% | 28.40% | 28.39% | 28.15% | 27.81% | 28.19% | 28.35% | 27.78% | 27.93% | 27.19% | 27.07% | 26.52% | 26.70% | 28.16% | 28.42% | 28.46% | 28.77% | 28.96% | 29.29% | 29.66% | 29.42% | 29.29% | 29.53% | 29.13% | 29.65% | 30.18% | 31.16% | 31.54% | 31.75% |
| Research & Development | 0.00 | 371.00M | 307.00M | 284.00M | 300.00M | 260.00M | 254.00M | 245.00M | 238.00M | 178.00M | 127.00M | 105.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.62B | 24.70B | 24.13B | 23.03B | 22.30B | 22.60B | 23.97B | 23.05B | 22.83B | 21.18B | 17.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 694.00M | 775.00M | 862.00M | 772.00M | 532.00M | 582.00M | 665.00M | 571.00M | 598.00M | 491.00M | 265.00M | 286.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.11B | 25.48B | 24.99B | 23.80B | 22.84B | 23.18B | 24.64B | 23.62B | 23.43B | 21.67B | 17.69B | 17.47B | 16.88B | 16.56B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.52B | 3.84B | 3.33B | 2.97B | 2.66B | 2.39B | 2.16B | 1.93B | 1.74B | 1.58B | 1.41B | 1.28B | 1.19B | 1.07B | 914.00M | 791.70M |
| Other Expenses | 0.00 | 8.10B | 1.58B | 1.64B | 1.96B | -50.00M | -389.00M | -185.00M | 210.00M | 344.00M | -443.00M | 0.00 | 0.00 | -434.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| Operating Expenses | 40.60B | 33.95B | 26.88B | 25.73B | 25.10B | 23.39B | 24.50B | 23.68B | 23.87B | 22.19B | 17.38B | 16.98B | 16.88B | 16.13B | 15.52B | 14.37B | 13.20B | 12.09B | 10.47B | 9.36B | 8.06B | 6.95B | 5.98B | 5.18B | 4.75B | 4.05B | 3.52B | 3.14B | 2.81B | 2.52B | 2.28B | 2.03B | 1.83B | 1.67B | 1.48B | 1.34B | 1.25B | 1.12B | 957.80M | 826.10M |
| Cost & Expenses | 161.73B | 145.96B | 131.32B | 130.17B | 121.00B | 115.31B | 125.25B | 112.73B | 111.35B | 98.78B | 72.20B | 68.08B | 68.17B | 67.82B | 63.96B | 60.09B | 55.59B | 50.61B | 44.71B | 39.78B | 35.37B | 30.66B | 27.06B | 23.22B | 19.98B | 16.82B | 14.47B | 12.66B | 11.17B | 9.88B | 8.78B | 7.89B | 7.12B | 6.41B | 5.76B | 5.13B | 4.66B | 4.07B | 3.46B | 2.98B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 29.00M | 0.00 | 0.00 | 0.00 | 0.00 | 134.00M | 0.00 | 95.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 482.00M | 580.00M | 396.00M | 491.00M | 613.00M | 650.00M | 616.00M | 693.00M | 596.00M | 605.00M | 156.00M | 165.00M | 88.00M | 71.00M | 85.00M | 83.00M | 11.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.46B | 1.89B | 1.68B | 1.69B | 1.63B | 1.78B | 1.52B | 1.41B | 1.48B | 1.56B | 1.21B | 1.18B | 1.17B | 1.09B | 1.03B | 975.00M | 840.00M | 675.90M | 572.20M | 482.10M | 403.10M | 346.10M | 307.30M | 269.20M | 230.10M | 210.10M | 189.00M | 164.00M | 147.30M | 131.50M | 118.10M | 104.70M | 92.10M | 84.30M | 70.40M | 63.80M | 59.40M | 53.70M | 43.80M | 34.40M |
| EBITDA | -11.28B | 3.48B | 4.96B | 5.96B | 2.84B | 6.75B | 7.67B | 6.95B | 7.93B | 6.75B | 5.08B | 5.34B | 4.63B | 5.45B | 4.49B | 4.22B | 4.28B | 3.83B | 3.27B | 2.91B | 2.55B | 2.21B | 1.93B | 1.67B | 1.45B | 1.23B | 1.02B | 872.60M | 751.40M | 651.60M | 573.80M | 510.90M | 450.60M | 405.50M | 354.60M | 317.30M | 283.60M | 264.40M | 240.40M | 212.20M |
| EBITDA Ratio | -7.64% | -1.86% | 4.80% | 4.12% | 2.37% | 5.31% | 6.36% | 6.09% | 6.36% | 7.40% | 6.58% | 7.37% | 6.46% | 7.55% | 6.66% | 6.67% | 7.25% | 7.12% | 6.91% | 6.89% | 6.74% | 6.66% | 6.71% | 6.68% | 6.70% | 6.87% | 6.45% | 6.48% | 6.34% | 6.22% | 6.15% | 6.16% | 5.89% | 5.89% | 5.61% | 5.73% | 5.72% | 6.15% | 6.51% | 6.65% |
| Operating Income | -14.08B | -6.88B | 1.39B | 2.34B | 982.00M | 4.77B | 6.29B | 5.48B | 6.00B | 4.67B | 4.19B | 3.65B | 3.46B | 4.37B | 3.46B | 3.25B | 3.44B | 3.15B | 2.70B | 2.42B | 2.14B | 1.85B | 1.62B | 1.40B | 1.22B | 1.02B | 835.00M | 708.00M | 604.10M | 520.10M | 455.70M | 406.20M | 358.50M | 321.20M | 284.20M | 253.50M | 224.20M | 210.70M | 196.60M | 177.80M |
| Operating Income Ratio | -9.53% | -4.95% | 1.05% | 1.77% | 0.81% | 3.97% | 4.78% | 4.64% | 5.11% | 4.51% | 5.49% | 5.05% | 4.84% | 6.05% | 5.13% | 5.13% | 5.83% | 5.86% | 5.70% | 5.74% | 5.71% | 5.69% | 5.66% | 5.68% | 5.77% | 5.69% | 5.46% | 5.30% | 5.13% | 5.00% | 4.93% | 4.90% | 4.80% | 4.77% | 4.70% | 4.71% | 4.59% | 4.92% | 5.37% | 5.62% |
| Total Other Income/Expenses | -126.00M | 1.46B | 2.65B | 280.00M | -505.00M | -399.00M | -260.00M | -623.00M | -813.00M | 667.00M | -637.00M | -45.00M | -88.00M | -71.00M | -85.00M | -83.00M | -11.00M | 28.80M | 52.60M | -11.30M | 17.00M | 23.40M | 13.10M | 24.40M | 39.20M | 11.90M | 42.10M | 4.60M | 2.80M | 3.70M | 2.70M | -6.50M | -5.50M | -9.20M | -3.30M | -9.70M | -15.20M | -16.60M | -9.00M | -4.10M |
| Income Before Tax | -14.20B | -5.39B | 4.04B | 2.62B | 477.00M | 4.37B | 6.03B | 4.86B | 5.19B | 5.34B | 3.56B | 4.05B | 3.38B | 4.29B | 3.37B | 3.16B | 3.43B | 3.19B | 2.75B | 2.46B | 2.18B | 1.89B | 1.64B | 1.42B | 1.26B | 1.03B | 877.00M | 712.00M | 606.90M | 523.80M | 458.40M | 399.70M | 353.00M | 312.00M | 280.90M | 243.80M | 209.00M | 194.10M | 187.60M | 173.70M |
| Income Before Tax Ratio | -9.62% | -3.87% | 3.04% | 1.98% | 0.39% | 3.64% | 4.58% | 4.11% | 4.42% | 5.16% | 4.66% | 5.60% | 4.71% | 5.95% | 5.00% | 5.00% | 5.81% | 5.93% | 5.81% | 5.82% | 5.80% | 5.81% | 5.71% | 5.78% | 5.96% | 5.76% | 5.73% | 5.33% | 5.15% | 5.04% | 4.96% | 4.82% | 4.72% | 4.63% | 4.64% | 4.53% | 4.28% | 4.53% | 5.12% | 5.49% |
| Income Tax Expense | 1.25B | 1.86B | 30.00M | 667.00M | 339.00M | 577.00M | 998.00M | 760.00M | 997.00M | 1.06B | 1.53B | 1.50B | 1.25B | 1.58B | 1.28B | 1.16B | 1.27B | 1.15B | 1.00B | 896.10M | 816.10M | 713.00M | 618.10M | 537.10M | 486.40M | 403.20M | 340.00M | 276.00M | 235.20M | 203.00M | 176.50M | 154.40M | 132.40M | 117.00M | 106.30M | 89.60M | 79.90M | 90.60M | 84.50M | 79.50M |
| Net Income | -8.64B | -3.08B | 4.34B | 2.54B | 456.00M | 3.98B | 5.02B | 4.08B | 4.17B | 4.22B | 1.93B | 2.55B | 2.13B | 2.71B | 2.09B | 2.01B | 2.16B | 2.04B | 1.75B | 1.56B | 1.36B | 1.18B | 1.02B | 885.60M | 776.90M | 624.10M | 511.00M | 436.00M | 371.70M | 320.80M | 281.90M | 221.70M | 220.60M | 195.00M | 174.60M | 154.20M | 129.10M | 103.50M | 103.10M | 94.20M |
| Net Income Ratio | -5.85% | -2.21% | 3.27% | 1.92% | 0.37% | 3.32% | 3.82% | 3.45% | 3.56% | 4.08% | 2.53% | 3.53% | 2.97% | 3.76% | 3.10% | 3.17% | 3.65% | 3.80% | 3.69% | 3.70% | 3.63% | 3.62% | 3.55% | 3.60% | 3.66% | 3.50% | 3.34% | 3.26% | 3.16% | 3.09% | 3.05% | 2.67% | 2.95% | 2.90% | 2.89% | 2.87% | 2.64% | 2.42% | 2.82% | 2.98% |
| EPS | -10.01 | -3.57 | 5.02 | 2.31 | 0.20 | 4.14 | 5.07 | 3.80 | 3.85 | 4.05 | 2.03 | 2.69 | 2.43 | 2.97 | 2.13 | 2.03 | 2.18 | 2.04 | 1.73 | 1.53 | 1.32 | 1.14 | 1.00 | 0.87 | 0.77 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -10.01 | -3.57 | 5.01 | 2.30 | 0.20 | 4.13 | 5.05 | 3.78 | 3.82 | 4.00 | 2.00 | 2.67 | 2.42 | 2.94 | 2.12 | 2.02 | 2.17 | 2.03 | 1.72 | 1.52 | 1.31 | 1.13 | 0.99 | 0.86 | 0.76 | 0.62 | 0.26 | 0.22 | 0.38 | 0.33 | 0.28 | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 863.10M | 863.20M | 864.40M | 864.80M | 879.40M | 921.50M | 991.00M | 1.07B | 1.08B | 1.04B | 953.10M | 946.00M | 874.70M | 915.10M | 981.70M | 990.00M | 990.61M | 998.63M | 1.01B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.01B | 1.00B | 1.98B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
| Weighted Avg Shares Out (Dil) | 863.10M | 863.20M | 865.90M | 866.40M | 880.30M | 923.50M | 995.00M | 1.08B | 1.09B | 1.05B | 965.20M | 955.20M | 880.10M | 924.50M | 987.90M | 991.30M | 995.54M | 1.01B | 1.02B | 1.03B | 1.03B | 1.03B | 1.03B | 1.03B | 1.02B | 1.01B | 2.01B | 987.58M | 991.20M | 987.08M | 989.12M | 984.57M | 984.57M | 984.57M | 984.38M | 984.27M | 984.22M | 984.06M | 983.92M | 982.37M |
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Income investors have both good and not-so-good options in the healthcare sector.
Is Walgreens Boots Alliance Stock a Buy?
This pharmacy leader could be the comeback story of 2025.
2 "Safe" Healthcare Stocks That Are Anything But
If you buy these stocks, you might be in for serious disappointment when they underperform.
Why Walgreens Boots Alliance Rallied This Week
The company's earnings provided some hope for a turnaround -- but there's a long way to go.
These 15 Stocks Are Among the Top Dividend Payers in the S&P 500
The Standard & Poor's 500 Index was created by credit agency Standard & Poor's in 1957.
Walgreens Rallies on Store Closure Plan. Is the Stock a Buy Now?
Has Walgreens stock finally put in a bottom?
Why Did Walgreens Stock Rise 20%?
Walgreens recently reported its Q4'24 results (fiscal ends in August), with revenue and earnings exceeding our expectations. The company reported revenue of $37.5 billion and adjusted earnings of $0.39 per share, compared to our estimates of $34.9 billion, and $0.38,...
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
There's more to any investment than a single number.
Walgreens: Cautious Optimism After Earnings (Rating Upgrade)
I initially pitched a short on Walgreens with a price target of $8.35, but the stock reached that target faster than expected. WBA's Q4 earnings call showed a clear commitment to a turnaround, especially with management putting a focus on...
This High-Yield Dividend Stock Just Soared 15%. Time to Jump on Board?
Retail pharmacy giant Walgreens Boots Alliance (NASDAQ:WBA) was on a long downward slide long before 2024 began.
Source: https://incomestatements.info
Category: Stock Reports